Home/Tenvie Therapeutics/Don O'Sullivan
DO

Don O'Sullivan

Chief Business Officer

Tenvie Therapeutics

Tenvie Therapeutics Pipeline

DrugIndicationPhase
TN-783Obesity / Metabolic DysfunctionPreclinical